Author： Norman Peter
Publisher： Informa Healthcare
ISSN： 1354-3776
Source： Expert Opinion on Therapeutic Patents, Vol.15, Iss.12, 2005-12, pp. : 1817-1823
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Indole-based CXC chemokine receptor-2 antagonists
Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 5, 2003-05 ,pp. :
Access to resources
Recommend
The use of indole-3-acetic acids as CRTH2 receptor antagonists
Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 1, 2004-01 ,pp. :
Novel CRTH2 receptor antagonists
Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 1, 2005-01 ,pp. :
Novel CRTH2 antagonists: a review of patents from 2006 to 2009
Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 11, 2010-11 ,pp. :